Trial intelligence / Profile preview

Heliocare–midazolam CYP3A interaction in healthy Japanese volunteers

jRCTs031200220Completed

Start
Nov 2020
Modality
Small Molecules
Countries
2
01

Overview

Open-label, single-arm trial of Polypodium leucotomos. Primary endpoints: Serum midazolam AUC and Serum midazolam Cmax. Started Nov 2020; status: completed.

02

Drugs

Polypodium leucotomos

Beyond the preview

Go deeper on jRCTs031200220.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031200220.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call